Skip to main content
SpringerLink
Log in

Prognosis of Lymph Node Metastasis in Soft Tissue Sarcoma

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: We defined the tumor characteristics and prognosis of patients with regional lymph node metastasis (RLNM) from soft tissue sarcoma.

Methods: All patients with RLNM from soft tissue sarcoma were identified from the Royal Marsden Hospital Sarcoma Unit prospective database from January 1990.

Results: A total of 73 (3.4%) of 2127 patients had RLNM. Fifty-seven patients (78.1%) had RLNM as the first site of spread, and 16 patients (21.9%) presented with RLNM and distant metastasis synchronously. The most common histologies were rhabdomyosarcoma, epithelioid sarcoma, and angiosarcoma. There were 9 T1 and 36 T2 tumors, and tumor size was not available in 28 patients. There were 6 grade 1, 16 grade 2, and 51 grade 3 tumors. Forty-two patients presented with RLNM along with the primary tumor. Of the remaining patients, the median time to development of RLNM from diagnosis of the primary tumor was 13.5 months (95% confidence interval [CI], 1–100 months). The 1-year survival for patients with isolated RLNM was 77.49% (95% CI, 62.99%–86.88%), compared with 36.27% (95% CI, 13.32%–60.04%) for patients who presented with RLNM and distant metastasis (P = .005). The 1-year survival for metachronous and synchronous RLNM was 94.44% (95% CI, 66.64%–99.20%) and 67.54% (95% CI, 47.89%–81.12%), respectively (P = .05).

Conclusions: Lymph node metastasis is rare. Patients who present with isolated RLNM have an improved survival compared with patients who present with regional and distant metastasis at diagnosis. Synchronous RLNM with the primary tumor have a poorer outcome than metachronous RLNM in the absence of distant metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Lindberg RD, Martin RG, Romsdahl MM, Barkley HYT. Conservative surgery and postoperative radiotherapy in 300 adults with soft tissue sarcomas. Cancer 1981;47:2391–7.

    CAS  PubMed  Google Scholar 

  2. Karakousis CP. Soft tissue sarcomas: an update. Curr Surg 1982;39:5–11.

    CAS  PubMed  Google Scholar 

  3. Pisters PWT, Leung DHY, Woodruff J, Shi W, Brennan F. Analysis of prognostic factors in 1041 patients with localised soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1699–89.

    Google Scholar 

  4. Stefanovski PD, Bidoli E, Paoli ADC, et al. Prognostic factors in soft tissue sarcomas: a study of 395 patients. Eur J Surg Oncol 2002;28:153–64.

    CAS  PubMed  Google Scholar 

  5. Collin C, Godbold J, Hajdu S, Brennan MF. Localised extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol 1987;5:601–2.

    CAS  PubMed  Google Scholar 

  6. Weingrad DN, Rosenberg SA. Early lymphatic spread of osteogenic and soft tissue sarcomas. Surgery 1978;84:231–40.

    CAS  PubMed  Google Scholar 

  7. Rosenberg SA, Suit MD, Baker LH. Sarcoma of soft tissues. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology. Vol 2, 2nd ed. Philadelphia: Lippincott,1985:1243–91.

    Google Scholar 

  8. Russell WO, Cohen J, Enzinger F, et al. A clinical and pathological staging system for soft tissue sarcomas. Cancer 1977;40:1562–70.

    CAS  PubMed  Google Scholar 

  9. Shiu MH, Castro EB, Hadju SI, Fortner JG. Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg 1975;182:597–602.

    CAS  PubMed  Google Scholar 

  10. Mazeron JJ, Suit HD. Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer 1987;60:1800–8.

    CAS  PubMed  Google Scholar 

  11. Gerner RE, Moore GE, Pickren JW. Soft tissue sarcomas. Ann Surg 1975;181:803–8.

    Article  CAS  PubMed  Google Scholar 

  12. Fong Y, Coit DG, Woodruff JM, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 1993;217:72–7.

    CAS  PubMed  Google Scholar 

  13. Gaakeer HA, Albus-Lutter CE, Gortzak E, Zoetmulder FA. Regional lymph node metastases in patients with soft tissue sarcomas of the extremities, what are the therapeutic consequences? Eur J Surg Oncol 1988;14:151–6.

    CAS  PubMed  Google Scholar 

  14. Ruka W, Emrich LJ, Driscoll DL, Karakousis CP. Prognostic significance of lymph node metastasis and bone, major vessel, or nerve involvement in adults with high-grade soft tissue sarcomas. Cancer 1988;62:999–1006.

    CAS  PubMed  Google Scholar 

  15. Vezeridis MP, Moore R, Karakousis CP. Metastatic patterns in soft tissue sarcomas. Arch Surg 1983;118:915–8.

    CAS  PubMed  Google Scholar 

  16. AJCC Cancer Staging Manual. 6th Ed. 2003;193–200.

  17. Perneger TV. What’s wrong with Bonferroni adjustments. BMJ 1998;316:1236–8.

    CAS  PubMed  Google Scholar 

  18. Lee YT, Moore TM, Schwinn CP. Metastasis of sarcomatous lesion in regional lymph node. J Surg Oncol 1982;20:53–8.

    CAS  PubMed  Google Scholar 

  19. Lal P, Sharma R, Mohan H, Sekhon MS. Dermatofibrosarcoma protuberans metastasizing to lymph nodes: a case report and review of literature. J Surg Oncol 1999;72:178–80.

    CAS  PubMed  Google Scholar 

  20. Petoin DS, Verola O, Banzet P, et al. Dermatofibrosarcoma de Darier et Ferranel: etude de 96 cas sur 15 ans. Chirurgie 1985;111:132–5.

    CAS  PubMed  Google Scholar 

  21. Fine G, Ohorodnik JM, Horn RC. Soft tissue sarcomas: their clinical behaviour and course and influencing factors. In: Seventh National Cancer Conference Proceeding. Philadelphia: Lippincott,1974:873–82.

    Google Scholar 

  22. Billingsley K, Burt ME, Jara E, et al. Pulmonary metastases from soft tissue sarcoma. Ann Surg 1999;229:602–12.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sarcoma and Melanoma Unit, Royal Marsden NHS Trust, United Kingdom

    Kasim A. Behranwala MS, DNB, FRCS (Ed), FRCS (Glas), Roger A’Hern MSc, Al-Muderis Omar BSc & J. Meirion Thomas MS, FRCS, FRCP

  2. Sarcoma and Melanoma Unit, Royal Marsden NHS Trust, 203 Fulham Road, London, SW3 6JJ, UK

    Kasim A. Behranwala MS, DNB, FRCS (Ed), FRCS (Glas)

Authors
  1. Kasim A. Behranwala MS, DNB, FRCS (Ed), FRCS (Glas)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger A’Hern MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Al-Muderis Omar BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Meirion Thomas MS, FRCS, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kasim A. Behranwala MS, DNB, FRCS (Ed), FRCS (Glas).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Behranwala, K.A., A’Hern, R., Omar, AM. et al. Prognosis of Lymph Node Metastasis in Soft Tissue Sarcoma. Ann Surg Oncol 11, 714–719 (2004). https://doi.org/10.1245/ASO.2004.04.027

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2004.04.027

Key Words:

Search

Navigation